Dedicated to International Education
in Laboratory Hematology
Officers | Join | Contact Us


  • Home
  • About ISLH
    • Quick Tips
    • History
    • Board
    • Committees
    • Guidelines
    • Mission
    • Bylaws
    • Conflict of Interest
    • Contact
  • Membership
  • Conference
  • Education
  • Guidelines
  • Journal
  • Contact Us

Inventory of Guidelines

ISLH is committed to ensuring an up to date inventory of guidelines that support the Hematology Laboratory community. To this end, below are additional guidelines.

Pre-analytical

Optimal Testing: AACC’s Guide to Lab Test Utilization

AACC

2020

View

Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis

BSH

2020

View

Strategies for eliciting and synthesizing evidence for guidelines in rare diseases

BMC

2019

View

Reversal of direct oral anticoagulants: Guidance from the Anticoagulation Forum

Anticoagulation Forum

2019

View

Croatian Society of Medical Biochemistry and Laboratory Medicine: National recommendations for blood collection, processing, performance and reporting of results for coagulation screening assays prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen and D-dimer.

Croatian Society of Medical Biochemistry and Laboratory Medicine

2019

View

Joint EFLM-COLABIOCLI Recommendation for venous blood sampling

EFLM-COLABIOCLI

2018

View

Hematopathology

Nucleic acid amplification assays for molecular hematopathology:  Approved Guideline – second edition

CLSI
(this is now listed as a hematology document)

2012

View

Coagulation

Recommendations for clinical laboratory testing of activated protein C resistance; communication from the SSC of the ISTH

  ISTH / SSC

2019

View

 

Internal quality control practices in coagulation laboratories: recommendations based on a patterns-of-practice survey

IQMH

2015

View

Additional Information

Diagnosis of inherited platelet function disorders:  guidance from the SSC of the ISTH

ISTH

2015

View

Testing for antiphospholipid antibodies with solid phase assays: guidance from the SSC of the ISTH

ISTH

2014

View

Validation of hemostasis and coagulation assays: recommendations and guidelines

Independent authors (STH)

2014

View

Additional Information

The diagnosis and management of von Willebrand disease: a United Kingdom Haemophilia Centre Doctors Organization guideline approved by the British Committee for Standards in Haematology

UKHCDO / BCSH

2014

View

European evidence-based recommendations for diagnosis and treatment of paediatric antiphospholipid syndrome: the SHARE initiative

NIH

2017

View

Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations

NIH

2017

View

Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL

Blood Transfusion

2017

View

International Council for Standardization in Haematology (ICSH) Recommendations for Laboratory Measurement of Direct Oral Anticoagulants

ICSH

2018

View

Laboratory criteria for antiphospholipid syndrome: communication from the SSC of the ISTH

ISTH SSC

2018

View

Lupus anticoagulant detection in anticoagulated patients. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis

ISTH SSC

2020

View

Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis

 

ISTH SSC

2020

View

Update of the guidelines for lupus anticoagulant detection and interpretation

ISTH SSC

2020

View

Recommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTH

 

ISTH SSC

2020

View

Recommendations for clinical laboratory testing for protein S deficiency: Communication from the SSC committee plasma coagulation inhibitors of the ISTH

ISTH SSC

2021

View

Hemoglobinopathies and other red cell disorders

ICSH recommendations for assessing automated high-performance liquid chromatography and capillary electrophoresis equipment for the quantitation of HbA2

ICSH

2015

View

ICSH guidelines for the laboratory diagnosis of nonimmune hereditary red cell membrane disorders

 

Supporting information

ICSH

2015

View

 

 

Additional Information

ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes

ICSH

2011

View

ICSH recommendations for identification, diagnostic value, and quantitation of schistocytes

ICSH

2011

View

Cellular analysis, including peripheral blood, bone marrow and body fluid analysis

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

WHO

2016

View

 

ICSH recommendations for the standardization of nomenclature and grading of peripheral blood cell morphological features

Supporting information

ICSH

2015

View

 

Additional Information

ICSH guidelines for the standardization of bone marrow immunohistochemistry

ICSH

2015

View

ICSH guidelines for the evaluation of blood cell analyzers including those used for differential leucocyte and reticulocyte counting

ICSH

2014

View

ICSH guidelines for the verification and performance of automated cell counters for body fluids

ICSH

2014

View

Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology

CAP

2016

View

Flow Cytometry

 

Immunophenotyping of acute leukemia and lymphoproliferative disorders: a consensus proposal of the European LeukemiaNet Work package 10

ESCCA

2011

View

Additional Information

Minimal Residual Disease and Childhood Leukemia: Standard of Care Recommendations From the Pediatric Oncology Group of Ontario MRD Working Group

PBC

2016

View

ICCS/ESCCA consensus guidelines to detect GPI-deficient cells in paroxysmal nocturnal hemoglobinuria (PNH) and related disorders

Part 1 – clinical utility
Part 2 – reagent selection and assay optimization for high-sensitivity testing
Part 3 – data analysis, reporting and case studies
Part 4 – assay validation and quality assurance

ICCS/ESCCA

2018

View

 

The following guidelines are not restricted to laboratory testing:

A British Society for Haematology Guideline on the diagnosis and management of chronic myeloid leukaemia

BSH

2020

View

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)

ECS

2020

View

Standardizing Care to Manage Bleeding Disorders in Adolescents with Heavy Menses—A Joint Project from the ISTH Pediatric/Neonatal and Women's Health SSCs

ISTH SSC

2020

View

WFH Guidelines for the Management of Hemophilia, 3rd edition

WFH

2020

View

Investigation and management of erythrocytosis

 

2020

View

Guideline for the diagnosis and management of the rare coagulation disorders.  A United Kingdom Haemophilia Centre Doctors’ Organization guideline on behalf of the British Committee for Standards in Haematology

UKHCDO
/ BCSH

2014

View

Patient self-testing and self-management oforal anticoagulant with vitamin K antagonists: guidance from the British Committee for Standards in Haematology

BCSH

2014

View

Diagnosis and management of acquired coagulation inhibitors: a guideline form UKHCDO

UKHCDO
/ BCSH

2013

View

Diagnosis and treatment of factor VIII and IX inhibitors in congenital haemophilia: (4th edition)

UKHCDO
/ BCSH

2013

View

Review of the NICE guidelines for multiple myeloma

NCBI

2017

View

WFH Guidelines for the Management of Hemophilia, 2nd edition

WFH

2012

View

McMaster RARE-Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome

McMaster RARE-Bestpractices project group

2018

View

European Myeloma Network recommendations on tools for the diagnosis and monitoring of multiple myeloma: what to use and when

European Myeloma Network

2018

View

EULAR recommendations for the management of antiphospholipid syndrome in adults

EULAR

2019

View

Guidelines on the use of therapeutic apheresis in clinical practice - Evidence-based approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Edition

American Society for Apheresis

2019

View

Acquired hemophilia A: Updated review of evidence and treatment guidance.

Hemostasis and Thrombosis Research Society of North America (HTRS)

2017

View

Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET

AICE

2020

View

ISTH Guidelines for Treatment of Thrombotic Thrombocytopenic Purpura

ISTH

2020

View

International Recommendations On The Diagnosis And Treatment Of Acquired Hemophilia A


2020

View

Anticoagulant therapy for splanchnic vein thrombosis

ISTH SSC

2020

View

Use of direct oral anticoagulants in patients with thrombotic antiphospholipid syndrome: Guidance from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis

ISTH SSC

2020

View

Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia

 

2020

View

Good practice statements (GPS) for the clinical care of patients with thrombotic thrombocytopenic purpura

ISTH

2020

View

American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism

ASH

2020

View

Canadian stroke best practice recommendations: Management of Spontaneous Intracerebral Hemorrhage, 7th Edition Update 2020

Canadian Stroke Best Practice Recommendations (CSBPR)

2020

View

2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee

ACC

2020

View

2021 Guidelines on the Diagnosis and Management of VWD

ASH, ISTH, NHF, WFH

2021

View

Management of hemostatic complications in acute leukemia: Guidance from the SSC of the ISTH

ISTH SSC

2020

View

Post-analytical

Recommendations on the Standardization of Critical Results in Hematology – Adult Population

ICSH

2016

View

Guideline Papers

ICSH

2018

View

Guideline Papers

BSH

2016

View

International Council for Standardization in Haematology Recommendations for Hemostasis Critical Values, Tests, and Reporting

ICSH

2020

View

Comprehensive review of the impact of direct oral anticoagulants on thrombophilia diagnostic tests: Practical recommendations for the laboratory

 

2020

View

American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer

ASH

2021

View

Coagulopathy and Hematology Guidance related to COVID-19

Disclaimer: COVID-19 research and publications is rapidly evolving. ISLH will strive to have the most up-to-date resources available however there may be some delay in posting.   

Remdesivir for severe covid-19: a clinical practice guideline

BMJ Rapid Recommendation

2020

View

IFCC Information Guide on COVID-19

IFCC

2020

View

Thromboembolism and Anticoagulant Therapy During the COVID-19 Pandemic: Interim Clinical Guidance from the Anticoagulant Forum

Anticoagulant Forum

2020

View

ISTH interim guidance on recognition and management of coagulopathy in COVID-

ADDENDUMS to above publication:

ISTH interim guidance on recognition and management of coagulopathy in COVID-19: A Comment

ISTH interim guidance to recognition and management of coagulopathy in COVID-19

Laboratory haemostasis monitoring in COVID-19

ISTH

2020

View

 

 

 

 

View

 

 

 

View

 

 

View

Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19

Chinese Society on Thrombosis and Hemostasis

2020

View

Practical guidance for the management of adults with Immune Thrombocytopenia during the COVID-19 pandemic

Reviewed by UK ITP Forum

2020

View

Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19

ISTH SSC

2020

View

Prevention, diagnosis and treatment of venous thromboembolism in patients with COVID-19: CHEST Guideline and Expert Panel Report

CHEST

2020

View

The need for accurate D-dimer reporting in COVID-19: Communication from the ISTH SSC on Fibrinolysis

ISTH SSC

2020

View

COVID-19 and its implications for thrombosis and anticoagulation

ASH

2020

View

A Systematic Approach for Managing Venous Thromboembolism in Patients with COVID-19 - International Society on Thrombosis and Haemostasis, Inc.

ISTH

2020

View

Testing for SARS-CoV-2 (COVID-19): a systematic review and clinical guide to molecular and serological in-vitro diagnostic assays

 

2020

View

Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence based guideline

 

2020

View

Consensus-Based Clinical Recommendations and Research Priorities for Anticoagulant Thromboprophylaxis in Children Hospitalized for COVID-19 Related Illness

ISTH SSC

2020

View

Management of the thrombotic risk associated with COVID-19: Guidance for the hemostasis laboratory

 

2020

View

ISTH DIC subcommittee communication on anticoagulation in COVID-19

ISTH SSC

2020

View

Quality of early evidence on the pathogenesis, diagnosis, prognosis and treatment of COVID-19

 

2020

View

Venous Thromboembolism in COVID-19

 

2020

View

Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality

 

2020

View

The hematology laboratory’s response to the COVID-19 pandemic: A scoping review

 

2020

View

Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis

 

2020

View

Routine laboratory testing to determine if a patient has COVID-19

Cochrane COVID-19 Diagnostic Test Accuracy Group

2020

View

The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Molecular Diagnostic Testing

Infectious Diseases Society of America

2021

View

ASH Guidelines on Use of Anticoagulation in Patients with COVID-19

ASH

2021

View

The ADAMTS13-von Willebrand factor axis in COVID-19 patients

 

2021

View

A living WHO guideline on drugs to prevent covid-19

WHO

2021

View

Thrombosis Canada Statement on Astrazeneca COVID-19 Vaccine and Thrombosis

Thrombosis Canada

2021

View

ISTH Statement on Astrazeneca COVID-19 Vaccine and Thrombosis

ISTH

2021

View

THROMBOSIS CANADA UPDATED STATEMENT ON ASTRAZENECA VACCINE AND BLOOD CLOTS Thrombosis Canada seeks to reassure the public regarding blood clot risk and COVID-19 vaccines

Thrombosis Canada

2021

View

COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets

European Medicines Agency (EMA)

2021

View






    Account Login




  • Forget your password?

Copyright 2020 by the International Society for
Laboratory Hematology. All rights reserved.

Conference and meeting services SPLtrak a division of SPLhost
Society management services SPLtrak a division of SPLhost